What BARAKAT Pharmaceutical Industries does

BARAKAT Pharmaceutical Industries is a private, for-profit pharmaceutical manufacturer headquartered in Aleppo, Syria, founded in 1972. The company manufactures generic medicines and medical solutions, supplying its products to three B2B customer categories: pharmacies, hospitals, and distributors. With a reported headcount of 251–500 employees, it operates as a mid-sized producer within the Syrian and regional generic-pharmaceuticals segment. The firm is privately held and not publicly listed.

Beyond these firmographic anchors, primary operational detail is limited. The company's website (barakat-pharma.com) returned only a loading/verification page during data collection, so specific product SKUs, therapeutic-area coverage, manufacturing capacity, regulatory certifications (e.g., GMP, local MoH approvals), export markets, pricing models, distribution-contract structure, and financial performance are not directly verifiable from the available sources. No management team, funding-round history, ownership structure, partnership disclosures, or technology-stack information was extractable. As a result, the description of the business model and underlying technology is necessarily thin: BARAKAT appears to operate a conventional generic-pharma manufacturing and B2B distribution model targeting domestic institutional and retail buyers, but the precise revenue mechanics, product mix, and technical platforms remain undocumented in the current dataset.

Name

BARAKAT Pharmaceutical Industries

Website

https://barakat-pharma.com

Company type

Private

Founded year

1972

Headcount range

251–500 employees

Short description

BARAKAT Pharmaceutical Industries is a Syria-based (Aleppo) private manufacturer of generic medicines and medical solutions, founded in 1972 and employing 251–500 people, supplying pharmacies, hospitals, and distributors.

Ownership category

akta.pro rank

Product category

Generic Pharmaceuticals

NAICS

Pharmaceutical Preparation Manufacturing (325412)

SIC

Pharmaceutical Preparations (2834)

akta.pro primary industry

Generic Hospital & Institutional Products (HLAIABAL)

Keywords

• Generic pharmaceuticals
• Pharmaceutical manufacturing
• Generic medicines
• Medical solutions
• Pharmaceutical products

Headquarters

HQ city

Aleppo

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Personnel, Infrastructure, Technology or R&D

Core offering

BARAKAT Pharmaceutical Industries manufactures generic medicines and medical solutions. The company produces pharmaceutical products for distribution to pharmacies, hospitals, and distributors, operating as a pharmaceutical manufacturer established in Aleppo.

Differentiator

Problem solved

Functional benefit

Products and services

• Generic Medicines
• Medical Solutions

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Direct peers

• Julphar (Gulf Pharmaceutical Industries): UAE-based generic medicines and medical solutions manufacturer supplying hospitals, pharmacies, and distributors across MENA. Closely comparable to BARAKAT on product mix (generics + solutions/infusions) and on multi-channel institutional distribution.
• EVA Pharma: Egypt-based generics and medical solutions producer with hospital, pharmacy, and export channels. Comparable to BARAKAT on its generics + solutions portfolio and on its multi-channel distribution model targeting institutional buyers.
• Dar Al Dawa: Jordanian generic pharmaceutical manufacturer with regional distribution across MENA. Comparable to BARAKAT on generic dosage-form manufacturing and on institutional/retail distribution in neighboring markets.
• Spimaco Addwaeih: Saudi Arabian generic pharmaceutical manufacturer with a broad portfolio of generics and medical solutions. Comparable to BARAKAT on generic manufacturing scale, hospital channel exposure, and distribution via wholesalers and direct accounts.
• Tabuk Pharmaceuticals: Saudi-based generic pharmaceutical manufacturer producing branded generics and hospital products distributed via pharmacies, hospitals, and wholesalers. Comparable to BARAKAT on generics manufacturing and multi-channel institutional/retail distribution in MENA.
• EIPICO (Egyptian International Pharmaceutical Industries): One of the largest generic pharmaceutical manufacturers in Egypt, producing tablets, capsules, injectables, and medical solutions. Comparable to BARAKAT on generic manufacturing breadth and on serving both pharmacy and hospital channels across the region.

Broad incumbents

• Pharco Pharmaceuticals: Large Egyptian pharmaceutical group manufacturing generics, medical solutions, and hospital products across the MENA region. Comparable to BARAKAT as a regional generics and medical-solutions manufacturer with broad channel reach.
• Hikma Pharmaceuticals: Jordan-headquartered generic and specialty pharmaceutical manufacturer with a large injectable and hospital portfolio. Comparable to BARAKAT as a MENA-based producer of generics and hospital/medical solutions serving institutional buyers across the region.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat2 records

Key risks4 records

Key highlights4 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about BARAKAT Pharmaceutical Industries